Home / Top News / HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Canaan (CAN) Investors with Losses to Contact Its Attorneys Now, Securities Class Action Filed, Application Deadline Established
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Canaan (CAN) Investors with Losses to Contact Its Attorneys Now, Securities Class Action Filed, Application Deadline Established
SAN FRANCISCO, May 08, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Canaan Inc. (NASDAQ: CAN) investors with significant losses to submit your losses now. A securities class action has been filed and certain investors may have valuable claims.
Class Period: Feb. 10, 2021 – Apr. 9, 2021
Lead Plaintiff Deadline: June 14, 2021
Visit: www.hbsslaw.com/investor-fraud/CAN
844-916-0895
Home / Top News / RMO SECURITIES FRAUD: HAGENS BERMAN, National Trial Attorneys, Alerts Romeo Power (RMO) Investors to Securities Class Action, Encourages Investors with Losses to Contact the Firm
RMO SECURITIES FRAUD: HAGENS BERMAN, National Trial Attorneys, Alerts Romeo Power (RMO) Investors to Securities Class Action, Encourages Investors with Losses to Contact the Firm
SAN FRANCISCO, May 08, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Romeo Power, Inc.
(NYSE: RMO) investors with significant losses to submit your losses now. A securities class action has been filed and certain investors may have valuable claims.
Class Period: Oct. 5, 2020 – Mar. 30, 2021
Lead Plaintiff Deadline: June 15, 2021
Visit: http://www.hbsslaw.com/cases/RMO
SAN FRANCISCO, May 08, 2021 (GLOBE NEWSWIRE) Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses.
Home / Top News / HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts FibroGen (FGEN) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors Should Secure Counsel
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts FibroGen (FGEN) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors Should Secure Counsel
SAN FRANCISCO, May 08, 2021 (GLOBE NEWSWIRE) Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses now.
Class Period: Oct. 18, 2017 – Apr. 6, 2021
Lead Plaintiff Deadline: June 11, 2021
Visit: www.hbsslaw.com/cases/FGEN
FibroGen, Inc. (NASDAQ: FGEN) Securities Fraud Action:
The complaint centers on FibroGen’s presentation of false data of roxadustat to make the anemia drug look safer than it is.
Home / Top News / HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Acadia Pharmaceuticals (ACAD) Investors to Securities Class Action and Application Deadline, Encourages Investors with Losses to Contact Its Attorneys Now
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Acadia Pharmaceuticals (ACAD) Investors to Securities Class Action and Application Deadline, Encourages Investors with Losses to Contact Its Attorneys Now
SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Acadia Pharmaceuticals Inc.
(NASDAQ: ACAD) investors with significant losses to submit your losses now.
Class Period: June 15, 2020 – Apr. 4, 2021
Lead Plaintiff Deadline: June 18, 2021
Visit: www.hbsslaw.com/investor-fraud/ACAD
844-916-0895
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) Securities Fraud Action: